Based on our findings, Nrf2 and CXCR4 levels in relapsed B-ALL patients significantly increased relative to normal healthy blood donors, which were also confirmed in Nalm-6/RS4; 11 cells. This evidence concerns the gene CXCR4 and precursor B-cell acute lymphoblastic leukemia.